Discover the DMD therapeutics market's expansion to US$6.64 billion by 2033 with 13.2% CAGR. Key insights on North America's 43.5% share, molecular-based therapies' 45.1% dominance, and intravenous administration's rise fueled by collaborative biotech efforts and genetic testing trends. https://finance.yahoo.com/news/duchenne-muscular-dystrophy-therapeutics-market-083800204.html